AUPH logo

Aurinia Pharmaceuticals Inc. (AUPH) Cash From Investing

Annual CFI:

$39.26M+$45.97M(+685.48%)
December 31, 2024

Summary

  • As of today, AUPH annual cash from investing is $39.26 million, with the most recent change of +$45.97 million (+685.48%) on December 31, 2024.
  • During the last 3 years, AUPH annual cash from investing has risen by +$143.13 million (+137.80%).
  • AUPH annual cash from investing is now at all-time high.

Performance

AUPH Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

Quarterly CFI:

-$14.04M-$1.09M(-8.39%)
September 30, 2025

Summary

  • As of today, AUPH quarterly cash from investing is -$14.04 million, with the most recent change of -$1.09 million (-8.39%) on September 30, 2025.
  • Over the past year, AUPH quarterly cash from investing has dropped by -$3.54 million (-33.71%).
  • AUPH quarterly cash from investing is now -115.42% below its all-time high of $91.05 million, reached on December 31, 2017.

Performance

AUPH Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

TTM CFI:

$42.47M-$3.54M(-7.69%)
September 30, 2025

Summary

  • As of today, AUPH TTM cash from investing is $42.47 million, with the most recent change of -$3.54 million (-7.69%) on September 30, 2025.
  • Over the past year, AUPH TTM cash from investing has increased by +$48.63 million (+789.96%).
  • AUPH TTM cash from investing is now -43.49% below its all-time high of $75.16 million, reached on September 30, 2018.

Performance

AUPH TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AUPH Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+685.5%-33.7%+790.0%
3Y3 Years+137.8%+71.5%+168.6%
5Y5 Years+404.5%+90.5%+123.6%

AUPH Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+137.8%-128.5%+71.5%-7.7%+168.6%
5Y5-Yearat high+124.8%-128.5%+90.5%-7.7%+119.5%
All-TimeAll-Timeat high+124.8%-115.4%+90.5%-43.5%+119.5%

AUPH Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$14.04M(-8.4%)
$42.47M(-7.7%)
Jun 2025
-
-$12.95M(-141.7%)
$46.01M(+127.1%)
Mar 2025
-
$31.03M(-19.2%)
$20.26M(-47.3%)
Dec 2024
$39.26M(+685.5%)
$38.42M(+466.0%)
$38.46M(+724.8%)
Sep 2024
-
-$10.50M(+72.9%)
-$6.16M(+60.1%)
Jun 2024
-
-$38.70M(-178.6%)
-$15.43M(-187.0%)
Mar 2024
-
$49.23M(+894.8%)
$17.73M(+366.8%)
Dec 2023
-$6.71M(+88.9%)
-$6.19M(+68.7%)
-$6.65M(-232.4%)
Sep 2023
-
-$19.77M(-256.9%)
-$2.00M(+93.6%)
Jun 2023
-
-$5.54M(-122.3%)
-$31.46M(-259.4%)
Mar 2023
-
$24.86M(+1705.8%)
$19.74M(+133.9%)
Dec 2022
-$60.63M(+41.6%)
-$1.55M(+96.9%)
-$58.14M(+6.2%)
Sep 2022
-
-$49.23M(-207.8%)
-$61.95M(-40.6%)
Jun 2022
-
$45.65M(+186.1%)
-$44.07M(+50.5%)
Mar 2022
-
-$53.02M(-889.2%)
-$89.07M(+13.8%)
Dec 2021
-$103.87M(+34.3%)
-$5.36M(+82.9%)
-$103.30M(-27.5%)
Sep 2021
-
-$31.35M(-4912.5%)
-$81.05M(+58.9%)
Jun 2021
-
$651.40K(+101.0%)
-$197.07M(+9.6%)
Mar 2021
-
-$67.25M(-498.0%)
-$217.95M(-33.9%)
Dec 2020
-$158.19M(-2132.5%)
$16.90M(+111.5%)
-$162.83M(+9.4%)
Sep 2020
-
-$147.37M(-628.5%)
-$179.78M(-455.7%)
Jun 2020
-
-$20.23M(-66.8%)
-$32.35M(-294.8%)
Mar 2020
-
-$12.13M(>-9900.0%)
-$8.20M(-204.8%)
Dec 2019
$7.78M(>+9900.0%)
-$50.50K(-193.7%)
$7.82M(-67.0%)
Sep 2019
-
$53.90K(-98.6%)
$23.69M(+33.8%)
Jun 2019
-
$3.93M(+1.0%)
$17.70M(-25.8%)
Mar 2019
-
$3.89M(-75.4%)
$23.85M(>+9900.0%)
Dec 2018
-$66.00K(+99.2%)
$15.82M(+366.5%)
-$64.80K(-100.1%)
Sep 2018
-
-$5.94M(-159.0%)
$75.16M(+1024.6%)
Jun 2018
-
$10.07M(+150.3%)
-$8.13M(+67.7%)
Mar 2018
-
-$20.02M(-122.0%)
-$25.15M(-207.7%)
Dec 2017
-$8.00M(-180.1%)
$91.05M(+202.0%)
-$8.17M(+91.5%)
Sep 2017
-
-$89.22M(-1184.6%)
-$96.37M(-1221.3%)
Jun 2017
-
-$6.95M(-127.9%)
-$7.29M(-286.2%)
Mar 2017
-
-$3.05M(-207.1%)
$3.92M(-60.5%)
Dec 2016
$9.99M(>+9900.0%)
$2.85M(+2057.1%)
$9.92M(+40.2%)
Sep 2016
-
-$145.40K(-103.4%)
$7.07M(-2.3%)
Jun 2016
-
$4.26M(+44.3%)
$7.24M(+145.9%)
Mar 2016
-
$2.96M(>+9900.0%)
$2.94M(>+9900.0%)
Dec 2015
-$23.00K(+99.8%)
-$100.00(-100.5%)
-$22.10K(-108.7%)
Sep 2015
-
$20.20K(+164.7%)
$255.40K(+102.6%)
Jun 2015
-
-$31.20K(-183.6%)
-$9.80M(+0.2%)
Mar 2015
-
-$11.00K(-104.0%)
-$9.82M(-0.1%)
Dec 2014
-$10.08M(>-9900.0%)
$277.40K(+102.8%)
-$9.81M(+2.9%)
Sep 2014
-
-$10.04M(>-9900.0%)
-$10.10M(>-9900.0%)
Jun 2014
-
-$47.00K(>-9900.0%)
-$96.00K(0.0%)
Mar 2014
-
$0.00(+100.0%)
-$96.00K(-166.7%)
Dec 2013
-$36.00K(-16.1%)
-$19.00K(+36.7%)
-$36.00K(-32.4%)
Sep 2013
-
-$30.00K(+36.2%)
-$27.20K(-5340.0%)
Jun 2013
-
-$47.00K(-178.3%)
-$500.00(-100.1%)
Mar 2013
-
$60.00K(+688.2%)
$885.60K(+2929.4%)
Dec 2012
-$31.00K
-$10.20K(-209.1%)
-$31.30K(+24.4%)
Sep 2012
-
-$3300.00(-100.4%)
-$41.40K(+11.2%)
DateAnnualQuarterlyTTM
Jun 2012
-
$839.10K(+197.9%)
-$46.60K(+95.0%)
Mar 2012
-
-$856.90K(-4121.2%)
-$929.70K(+19.0%)
Dec 2011
-$1.19M(-170.5%)
-$20.30K(-138.8%)
-$1.15M(-4.4%)
Sep 2011
-
-$8500.00(+80.7%)
-$1.10M(+3.2%)
Jun 2011
-
-$44.00K(+95.9%)
-$1.14M(-4.0%)
Mar 2011
-
-$1.08M(-3940.7%)
-$1.09M(-163.7%)
Dec 2010
$1.69M(+1224.3%)
$28.00K(+161.9%)
$1.71M(+5.9%)
Sep 2010
-
-$45.20K(>-9900.0%)
$1.62M(+3.3%)
Jun 2010
-
$100.00(-100.0%)
$1.57M(-69.6%)
Mar 2010
-
$1.73M(+2672.8%)
$5.16M(+3284.2%)
Dec 2009
-$149.90K(+60.6%)
-$67.30K(+30.2%)
-$161.90K(+15.5%)
Sep 2009
-
-$96.40K(-102.7%)
-$191.60K(-22.7%)
Jun 2009
-
$3.59M(+200.1%)
-$156.20K(+95.9%)
Mar 2009
-
-$3.59M(-3596.5%)
-$3.84M(-1046.5%)
Dec 2008
-$380.50K(-104.5%)
-$97.00K(-59.0%)
-$335.30K(-110.3%)
Sep 2008
-
-$61.00K(+39.4%)
$3.25M(-34.3%)
Jun 2008
-
-$100.60K(-31.2%)
$4.95M(-31.8%)
Mar 2008
-
-$76.70K(-102.2%)
$7.26M(-22.1%)
Dec 2007
$8.52M(-56.4%)
$3.49M(+113.1%)
$9.32M(-10.4%)
Sep 2007
-
$1.64M(-26.0%)
$10.40M(-27.9%)
Jun 2007
-
$2.21M(+11.2%)
$14.41M(-14.1%)
Mar 2007
-
$1.99M(-56.5%)
$16.77M(-13.8%)
Dec 2006
$19.55M(+178.2%)
$4.56M(-19.2%)
$19.46M(+11.9%)
Sep 2006
-
$5.65M(+23.6%)
$17.39M(+92.9%)
Jun 2006
-
$4.57M(-2.3%)
$9.01M(+22.5%)
Mar 2006
-
$4.68M(+87.9%)
$7.36M(+1.5%)
Dec 2005
$7.03M(+676.2%)
$2.49M(+191.3%)
$7.25M(+94.6%)
Sep 2005
-
-$2.73M(-193.5%)
$3.73M(+27.8%)
Jun 2005
-
$2.92M(-36.2%)
$2.92M(-66.3%)
Mar 2005
-
$4.57M(+541.4%)
$8.65M(+796.6%)
Dec 2004
$905.20K(+106.8%)
-$1.04M(+70.7%)
$965.20K(+108.5%)
Sep 2004
-
-$3.54M(-140.9%)
-$11.31M(-28.2%)
Jun 2004
-
$8.66M(+377.7%)
-$8.82M(+48.0%)
Mar 2004
-
-$3.12M(+76.6%)
-$16.98M(-19.6%)
Dec 2003
-$13.35M(+41.7%)
-$13.31M(-1169.6%)
-$14.20M(+18.0%)
Sep 2003
-
-$1.05M(-311.2%)
-$17.31M(+16.1%)
Jun 2003
-
$496.50K(+247.3%)
-$20.64M(+4.3%)
Mar 2003
-
-$337.00K(+97.9%)
-$21.56M(+5.8%)
Dec 2002
-$22.88M(-987.4%)
-$16.42M(-275.3%)
-$22.89M(-3070.6%)
Sep 2002
-
-$4.38M(-929.6%)
$770.50K(-4.8%)
Jun 2002
-
-$425.00K(+74.5%)
$809.50K(-18.0%)
Mar 2002
-
-$1.67M(-123.0%)
$986.90K(-60.9%)
Dec 2001
$2.58M(+134.4%)
-
-
Dec 2001
-
$7.24M(+266.9%)
$2.53M(+153.6%)
Sep 2001
-
-$4.34M(-1651.6%)
-$4.71M(-1159.9%)
Jun 2001
-
-$247.60K(-96.0%)
-$373.90K(-196.0%)
Mar 2001
-
-$126.30K(-630.7%)
-$126.30K(+10.3%)
Dec 2000
-$7.50M(-5293.0%)
-
-
Nov 1999
-$139.00K(-47.1%)
$23.80K(+115.9%)
-$140.80K(+14.5%)
Aug 1999
-
-$149.40K(-479.1%)
-$164.60K(-982.9%)
May 1999
-
-$25.80K(-343.4%)
-$15.20K(-243.4%)
Feb 1999
-
$10.60K
$10.60K
Nov 1998
-$94.50K
-
-

FAQ

  • What is Aurinia Pharmaceuticals Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. annual cash from investing year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. quarterly cash from investing year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. TTM cash from investing year-on-year change?

What is Aurinia Pharmaceuticals Inc. annual cash from investing?

The current annual cash from investing of AUPH is $39.26M

What is the all-time high annual cash from investing for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high annual cash from investing is $39.26M

What is Aurinia Pharmaceuticals Inc. annual cash from investing year-on-year change?

Over the past year, AUPH annual cash from investing has changed by +$45.97M (+685.48%)

What is Aurinia Pharmaceuticals Inc. quarterly cash from investing?

The current quarterly cash from investing of AUPH is -$14.04M

What is the all-time high quarterly cash from investing for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high quarterly cash from investing is $91.05M

What is Aurinia Pharmaceuticals Inc. quarterly cash from investing year-on-year change?

Over the past year, AUPH quarterly cash from investing has changed by -$3.54M (-33.71%)

What is Aurinia Pharmaceuticals Inc. TTM cash from investing?

The current TTM cash from investing of AUPH is $42.47M

What is the all-time high TTM cash from investing for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high TTM cash from investing is $75.16M

What is Aurinia Pharmaceuticals Inc. TTM cash from investing year-on-year change?

Over the past year, AUPH TTM cash from investing has changed by +$48.63M (+789.96%)
On this page